生命科学资讯

SanegeneBio raises $110M in follow-up to metabolic deal with Lilly

Novartis to partner with AI-focused Relation on atopic diseases

Stealthy biotech Sidera Bio raises $109M; Assembly's data for oral herpes drugs

Seven biotechs eye $2.3B in public offerings after data readouts

Radial raises $50M to treat mental health in non-traditional ways

#SABCS25: BioNTech, BMS unwrap Phase 2 data for PD-L1xVEGF-A bispecific in breast cancer

#ASH25: Eli Lilly's Jaypirca makes first-line case, but ceiling may be capped

Biosecure Act appears headed for final passage in defense bill

FDA sets new, higher bar for CAR-T cancer treatments to prove superiority

#ASH25: Will a biotech’s pivot away from obesity let it compete with Novartis in leukemia?

GSK walks away from remaining Ideaya programs

FDA misses PDUFA review deadline for Agios' thalassemia drug

Dyne says Duchenne drug succeeds in pivotal study, heads to FDA for approval

Cogent’s mastocytosis drug continues momentum, helps treat sicker patients

Day One was one of three parties interested in Mersana; Bihua Chen and Cormorant’s third SPAC

#ASH25: Kura, Syndax detail data for rival menin inhibitors as both eye earlier use in AML

Merck outbid three competitors in Cidara acquisition — new filing

Structure Therapeutics’ obesity pill stacks up with Novo and Lilly; Ascletis also reports early results

Kallyope heads to Phase 3 with migraine drug after mid-stage success

#ASH25: Star Therapeutics details early data for blood disorder shot, weighs IPO